US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

24.32

-0.1800-0.73%

Post-market: 23.97-0.3500-1.44%19:56 EDT

Volume:25.81K

Turnover:629.58K

Market Cap:56.42M

PE:- -

High:24.66

Open:24.66

Low:24.14

Close:24.50

52wk High:27.02

52wk Low:15.63

Shares:2.32M

Float Shares:2.32M

Volume Ratio:0.54

T/O Rate:1.11%

Dividend:1.71

Dividend Rate:7.01%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Compass Pathways Q2 Operating Expenses USD 52.372 Million

THOMSON REUTERS

Press Release: Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

Heavy Rare Earths plans major equity raising via pro rata offer and placement

Heavy Rare Earths Limited launches $2.0m capital raising to fund drilling and project review

Relmada Therapeutics Inc Expected to Post a Loss of 20 Cents a Share - Earnings Preview

Iceni Gold Plans Share and Option Issue to Bolster Exploration Funding

Kuniko plans equity and option issue to bolster capital base

Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72

Alkermes Amends 8-K to Disclose CEO Blair Jackson Pay Package Including $5 Million Equity Award

Compass Pathways PLC Expected to Post a Loss of 40 Cents a Share - Earnings Preview

Patagonia Lithium shareholders back capital raising and option changes at 2026 meeting

InSilico Medicine Wins China IND for AI-Designed Parkinson’s Drug

Yari Resources Plans Major Share and Option Placement to Expand Capital Base

Red Sky ramps up Innamincka drilling as capital raisings bolster cash

Grifols says EXCELL Phase 3 trial timeline not ‘new development or a delay’

Alkermes' Core Business Backed Q2 Beat, Orexin Pipeline to Serve as Catalyst, RBC Says

MT Newswires Live

Compass Pathways to Report Q2, First-half Results, Host Conference Call

Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026

THOMSON REUTERS

Microba Raises $5.4m Through Placement and SPP Ahead of FY26 Results

Alkermes Plc : Jefferies Raises Target Price to $72 from $65

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/PSIL/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":24.32,"timestamp":1789588800000,"preClose":24.5,"halted":0,"volume":25811,"hourTrading":{"tag":"盘后","latestPrice":23.97,"preClose":24.32,"latestTime":"19:56 EDT","volume":1038,"amount":24919.4073,"timestamp":1789603002316,"change":-0.35,"changeRate":-0.014391,"amplitude":0.014391},"delay":0,"changeRate":-0.007346938775510192,"floatShares":2319976,"shares":2319976,"eps":0,"marketStatus":"Closed","change":-0.18,"latestTime":"09-16 16:00:00 EDT","open":24.66,"high":24.66,"low":24.14,"amount":629579.3309,"amplitude":0.021224,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":24.5,"sharesOutstanding":1184976,"nav":24.374,"aum":56546897.05,"dividendRate":0.070115,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":25.06,"preClose":24.5,"latestTime":"08:44 EDT","volume":39,"amount":972.7199820000001,"timestamp":1789562657590,"change":0.56,"changeRate":0.022857,"amplitude":0.039592},"postHourTrading":{"tag":"盘后","latestPrice":23.97,"preClose":24.32,"latestTime":"19:56 EDT","volume":1038,"amount":24919.4073,"timestamp":1789603002316,"change":-0.35,"changeRate":-0.014391,"amplitude":0.014391},"volumeRatio":0.538481,"impliedVol":0.5167,"impliedVolPercentile":0.8645},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2319976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.538481,"shares":2319976,"dividePrice":1.7052,"high":24.66,"amplitude":0.021224,"preClose":24.5,"low":24.14,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":24.32,"eps":0,"divideRate":0.070115,"volume":25811,"delay":0,"ttmEps":0,"open":24.66,"prevYearClose":17.17,"prevWeekClose":24.7682,"prevMonthClose":24.62,"prevQuarterClose":24.05,"fiveDayClose":25.21,"twentyDayClose":26.2,"sixtyDayClose":21.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657548002","title":"Compass Pathways Q2 Operating Expenses USD 52.372 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657548002","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657548002?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:30","pubTimestamp":1785925800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLXD2DKG4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PSIL","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657354829","title":"Press Release: Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2657354829","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657354829?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:30","pubTimestamp":1785925800,"startTime":"0","endTime":"0","summary":"--  Data from two positive Phase 3 trials demonstrated rapid onset of. effect and durable benefit through at least 6 months, further validating. COMP360's potential to establish a new standard of care in TRD. --  COMP360 has a highly differentiated clinical profile and is expected to. --  Rolling NDA submission and initial review underway and final submission. --  Commercial launch expected in first half of 2027. --  COMP360 expected to fit seamlessly into current treatment. --  Strong cash position of $433 million at the end of second quarter,--  Compass management will host a conference call on August 5 at 8:00 am. options in mental health care -- moving beyond daily or frequent. administration toward an option that could potentially provide strong. efficacy with just a few treatments a year that could be life changing. --  Across two highly statistically significant positive Phase 3 trials,COMP360 is the first classic psychedelic1 to consistently demonstrate. rapid onset, sustained ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NPV","DEA","BK4139","BK4194","PSIL","BK4223","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657951495","title":"Heavy Rare Earths plans major equity raising via pro rata offer and placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2657951495","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657951495?lang=en_us&edition=fundamental","pubTime":"2026-08-05 08:37","pubTimestamp":1785890250,"startTime":"0","endTime":"0","summary":"Heavy Rare Earths Limited ( ($AU:HRE) ) has issued an announcement. Heavy Rare Earths Limited has lodged details of a proposed capital raising with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/heavy-rare-earths-plans-major-equity-raising-via-pro-rata-offer-and-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/heavy-rare-earths-plans-major-equity-raising-via-pro-rata-offer-and-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","SETM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657595104","title":"Heavy Rare Earths Limited launches $2.0m capital raising to fund drilling and project review","url":"https://stock-news.laohu8.com/highlight/detail?id=2657595104","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657595104?lang=en_us&edition=fundamental","pubTime":"2026-08-05 08:37","pubTimestamp":1785890234,"startTime":"0","endTime":"0","summary":"Heavy Rare Earths Limited ( ($AU:HRE) ) just unveiled an update. Heavy Rare Earths Limited has launched a capital raising of up to $2.028 million v...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/heavy-rare-earths-limited-launches-2-0m-capital-raising-to-fund-drilling-and-project-review?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/heavy-rare-earths-limited-launches-2-0m-capital-raising-to-fund-drilling-and-project-review?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","SETM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657600845","title":"Relmada Therapeutics Inc Expected to Post a Loss of 20 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657600845","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657600845?lang=en_us&edition=fundamental","pubTime":"2026-08-05 06:10","pubTimestamp":1785881405,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc <RLMD.OQ> expected to post a loss of20cents a share - Earnings PreviewRelmada Therapeutics IncRLMD.OQRLMD.Ois expected to  show no change in quarterly revenue when it reports ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N4413EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588643","title":"Iceni Gold Plans Share and Option Issue to Bolster Exploration Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588643","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588643?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:24","pubTimestamp":1785799494,"startTime":"0","endTime":"0","summary":"Iceni Gold Ltd. ( ($AU:ICL) ) has issued an update. Iceni Gold Ltd has outlined plans for a new capital raising via a proposed placement or similar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/iceni-gold-plans-share-and-option-issue-to-bolster-exploration-funding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/iceni-gold-plans-share-and-option-issue-to-bolster-exploration-funding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLD","NUGT","IAU","MGCmain","GDX","GCmain","SGUmain","518880","159934","PSIL","SGCmain","DUST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588694","title":"Kuniko plans equity and option issue to bolster capital base","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588694","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588694?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:24","pubTimestamp":1785799458,"startTime":"0","endTime":"0","summary":"Kuniko Ltd. ( ($AU:KNI) ) has shared an update. Kuniko Limited has lodged a new Appendix 3B with the ASX outlining a proposed capital raising throu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kuniko-plans-equity-and-option-issue-to-bolster-capital-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kuniko-plans-equity-and-option-issue-to-bolster-capital-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656300056","title":"Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72","url":"https://stock-news.laohu8.com/highlight/detail?id=2656300056","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656300056?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:10","pubTimestamp":1785798604,"startTime":"0","endTime":"0","summary":"Alkermes EVP, CLO David Joseph Gaffin sells 2,034 shares for $98,821.72David Joseph Gaffin, EVP and chief legal officer, sold 2,034 ordinary shares on Aug. 3, 2026 at USD 48.58.His direct stake fell t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL9zXC08:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","ALKS","BK4139","MEDX","PSIL","FBT","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656019363","title":"Alkermes Amends 8-K to Disclose CEO Blair Jackson Pay Package Including $5 Million Equity Award","url":"https://stock-news.laohu8.com/highlight/detail?id=2656019363","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656019363?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:09","pubTimestamp":1785787780,"startTime":"0","endTime":"0","summary":"Alkermes amends 8-K to disclose CEO Blair Jackson pay package including $5 million equity awardAlkermes amended a Feb. 25 Form 8-K on its CEO succession to add previously undetermined compensation ter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL2dlwWm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","MEDX","FBT","BK4139","ALKS","PSCH","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656537177","title":"Compass Pathways PLC Expected to Post a Loss of 40 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656537177","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656537177?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:11","pubTimestamp":1785762665,"startTime":"0","endTime":"0","summary":"Compass Pathways PLC <CMPS.OQ> expected to post a loss of40cents a share - Earnings PreviewCompass Pathways PLCCMPS.OQCMPS.Ois expected to  show no change in quarterly revenue when it reports  results","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4401E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656834496","title":"Patagonia Lithium shareholders back capital raising and option changes at 2026 meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2656834496","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656834496?lang=en_us&edition=fundamental","pubTime":"2026-08-03 09:47","pubTimestamp":1785721651,"startTime":"0","endTime":"0","summary":"Patagonia Lithium Limited ( ($AU:PL3) ) just unveiled an update. Patagonia Lithium Ltd has reported that all resolutions put to shareholders at its...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/patagonia-lithium-shareholders-back-capital-raising-and-option-changes-at-2026-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/patagonia-lithium-shareholders-back-capital-raising-and-option-changes-at-2026-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LIT","BK4588","BK4585","SETM","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656349689","title":"InSilico Medicine Wins China IND for AI-Designed Parkinson’s Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2656349689","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656349689?lang=en_us&edition=fundamental","pubTime":"2026-08-03 08:38","pubTimestamp":1785717492,"startTime":"0","endTime":"0","summary":"The latest announcement is out from InSilico Medicine Cayman TopCo ( ($HK:3696) ). InSilico Medicine has secured investigational new drug approval ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/insilico-medicine-wins-china-ind-for-ai-designed-parkinsons-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/insilico-medicine-wins-china-ind-for-ai-designed-parkinsons-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIX","CHAT","QTOC","TBXU","PSIL","VTHR","ARTY","AIPO","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656465933","title":"Yari Resources Plans Major Share and Option Placement to Expand Capital Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2656465933","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656465933?lang=en_us&edition=fundamental","pubTime":"2026-08-03 07:29","pubTimestamp":1785713343,"startTime":"0","endTime":"0","summary":"Consolidated Zinc Limited ( ($AU:YAR) ) has issued an update. Yari Resources has announced a proposed capital raising involving a large placement o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yari-resources-plans-major-share-and-option-placement-to-expand-capital-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yari-resources-plans-major-share-and-option-placement-to-expand-capital-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","DBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655443848","title":"Red Sky ramps up Innamincka drilling as capital raisings bolster cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2655443848","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655443848?lang=en_us&edition=fundamental","pubTime":"2026-07-30 07:53","pubTimestamp":1785369203,"startTime":"0","endTime":"0","summary":"Red Sky Energy Limited ( ($AU:ROG) ) has provided an announcement. Red Sky Energy has moved from planning into on‑ground activity at the Innamincka...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/red-sky-ramps-up-innamincka-drilling-as-capital-raisings-bolster-cash?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/red-sky-ramps-up-innamincka-drilling-as-capital-raisings-bolster-cash?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655890242","title":"Grifols says EXCELL Phase 3 trial timeline not ‘new development or a delay’","url":"https://stock-news.laohu8.com/highlight/detail?id=2655890242","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655890242?lang=en_us&edition=fundamental","pubTime":"2026-07-30 01:55","pubTimestamp":1785347731,"startTime":"0","endTime":"0","summary":"Grifols (GRFS) issued the following statement on the EXCELL Phase 3 trial timeline: “We have noted the recent Bloomberg article referring to the EX...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grifols-says-excell-phase-3-trial-timeline-not-new-development-or-a-delay-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grifols-says-excell-phase-3-trial-timeline-not-new-development-or-a-delay-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","GRFS","BK4139","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655926538","title":"Alkermes' Core Business Backed Q2 Beat, Orexin Pipeline to Serve as Catalyst, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2655926538","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655926538?lang=en_us&edition=fundamental","pubTime":"2026-07-29 23:53","pubTimestamp":1785340439,"startTime":"0","endTime":"0","summary":"Alkermes'  base business supported the company's Q2 beat, while its orexin pipeline serves as a potential catalyst for future revenue growth, RBC Capital Markets said in a Tuesday note.The company reported a breakeven in Q2, compared with earnings of $0.52 per share a year earlier, and revenue of $496 million, up from $390.7 million. For 2026, Alkermes reiterated its total revenue guidance of $1.73 billion to $1.84 billion.Alkermes' core business drove the quarter's revenue beat, with recent highlights like less generic threat for Vivitrol and expanded access for Lybalvi, RBC said. The quarter also said one-time benefits from patient mix favorability, Lumryz inventory and Consta manufacturing, the brokerage added.Looking forward, investor focus is shifting to the company's orexin pipeline expansion into other indications, which could help pave the way for Alkermes's revenue to exceed $5 billion, RBC noted.RBC has an outperform rating and $56 price target on Alkermes.Price: 48.40, Chang","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBRN","FBT","PSCH","BK4139","ALKS","PSIL","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655886917","title":"Compass Pathways to Report Q2, First-half Results, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2655886917","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655886917?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:31","pubTimestamp":1785321066,"startTime":"0","endTime":"0","summary":"Compass Pathways to report Q2, first-half results, host conference callCompass Pathways will report Q2 and first-half results for the period ended June 30, 2026 on Aug. 5, 2026.Management will host a ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL4ncJ40:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PSIL","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655910869","title":"Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655910869","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655910869?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:30","pubTimestamp":1785321000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA1JWLJD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPS","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655857841","title":"Microba Raises $5.4m Through Placement and SPP Ahead of FY26 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2655857841","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655857841?lang=en_us&edition=fundamental","pubTime":"2026-07-29 15:36","pubTimestamp":1785310579,"startTime":"0","endTime":"0","summary":"Microba Life Sciences Limited ( ($AU:MAP) ) has issued an update. Microba Life Sciences has completed a capital raising via a two-tranche placement...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/microba-raises-5-4m-through-placement-and-spp-ahead-of-fy26-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/microba-raises-5-4m-through-placement-and-spp-ahead-of-fy26-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655385647","title":"Alkermes Plc : Jefferies Raises Target Price to $72 from $65","url":"https://stock-news.laohu8.com/highlight/detail?id=2655385647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655385647?lang=en_us&edition=fundamental","pubTime":"2026-07-29 13:45","pubTimestamp":1785303957,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V0L1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","MEDX","PSCH","BK4139","IBRN","PSIL","FBT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}